8049 — Jilin Province Huinan Changlong Bio-pharmacy Share News
0.000.00%
Last trade - 00:00- HK$1.48bn
- HK$426.16m
- CNY901.87m
Brief: Jilin Province Huinan Changlong Bio-pharmacy Posts H1 Revenue Of RMB 435 million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Profit For Year Attributable Rmb198.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Structured Deposit Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product For RMB50 MLN
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Product For RMB50 MLN
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Recommended Payment Of Special Dividend
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts FY Profit Attributable RMB184.3 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribed For Wealth Management Product From ICBC For RMB20 MLN
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Product From ICBC
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts HY Profit Attributable RMB104.3 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Says Special Dividend Of RMB6.25 Cents Per Share Was Proposed
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Says Subscription Of Structured Deposit Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy says Subscriptions Of Wealth Management Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts 9M Profit Attributable Rmb133.3 Mln
Brief: HKEX Censures Jilin Province Huinan Changlong Bio-Pharmacy
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts Qtrly Profit Attributable RMB52.4 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Says Wealth Management Product In RMB20 Mln Subscribed
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co Says Subscribed For Wealth Management Product For Rmb30 Mln